TMS Co., Ltd.
4891.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.56B
Close$
Share Statistics
| Market cap | $5.56 Billion |
|---|---|
| Enterprise Value | $3.10 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-19.3 |
| Beta | 0.52 |
| Outstanding Shares | 45,579,157 |
Return
| Return on Equity | -36.55% |
|---|---|
| Return on Assets | -35.04% |
| Return on Invested Capital | -35.98% |
Valuation & Multiples
| P/E Ratio | -6.16 |
|---|---|
| PEG | 18.16 |
| Price to Sales | - |
| Price to Book Ratio | 2.35 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.57 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About TMS Co., Ltd.
18 employees
CEO: Takuro Wakabayashi Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceuticals, quasi-drugs, drug substances, medical devices, and various medical commod...